Patents-Review.com
🔗 Permalink
Assignee profile:

ORGENESIS INC.

City:

Germantown, Maryland

Country:

United States

Published Applications:

23

Last publication date:

2025-12-18

Patent Grants:

2

Last grant date:

2022-05-17

Top Inventors for applications by ORGENESIS INC.

These are the the leading inventors for applications assigned to ORGENESIS INC.:

Recent patent applications by ORGENESIS INC.

ORGENESIS INC. based in Germantown, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2025-12-18
US20250381229A1
Human necessities

HYDROGEL COMPOSITIONS CONTAINING CELLULAR PRODUCTS

 #2 | 2025-11-06
US20250339502A1
Human necessities

RIBONUCLEASES FOR TREATING VIRAL INFECTIONS

 #3 | 2025-05-15
US20250152697A1
Human necessities

AUTOLOGOUS CELL BASED SARS-COV-2 VACCINES

 #4 | 2025-05-15
US20250152642A1
Human necessities

NASAL ANTI-CANCER THERAPIES

 #5 | 2024-10-31
US20240358835A1
Human necessities

TUMOR INFILTRATING LYMPHOCYTES WITH INCREASED METABOLIC ACTIVITY

 #6 | 2024-10-24
US20240350975A1
Performing operations; transporting

SYSTEM AND METHOD FOR ULTRAFILTRATION AND CONCENTRATION OF BIOLOGICAL COMPONENTS WITHIN A LIQUID SUSPENSION

 #7 | 2024-07-11
US20240226210A9
Human necessities

ONCOLYTIC VIRUS COMBINED WITH CAR T CELLS FOR ANTI-TUMOR THERAPY

 #8 | 2024-06-13
US20240189425A1
Human necessities

CHIMERIC ANTIGEN RECEPTOR WITH MODIFIED HINGE AND TRANSMEMBRANE DOMAIN AND USES THEREOF

 #9 | 2024-06-06
US20240182852A1
Chemistry; metallurgy

CELL-CULTURE BIOREACTORS

 #10 | 2024-06-06
US20240180946A1
Human necessities

COMPOSITIONS COMPRISING TOPIRAMATE FOR TREATING DERMATOLOGICAL CONDITIONS

 #11 | 2024-04-25
US20240131096A1
Human necessities

ONCOLYTIC VIRUS COMBINED WITH CAR T CELLS FOR ANTI-TUMOR THERAPY

 #12 | 2024-04-18
US20240123043A1
Human necessities

PHARMACEUTICAL COMPOSITIONS COMPRISING RANPIRNASE

 #13 | 2023-11-30
US20230381230A1
Human necessities

CHIMERIC ANTIGEN RECEPTOR WITH MODIFIED HINGE REGION AND USES THEREOF

 #14 | 2023-05-11
US20230147602A1
Human necessities

RIBONUCLEASES FOR TREATING VIRAL INFECTIONS

 #15 | 2023-03-16
US20230077429A1
Chemistry; metallurgy

CELL-CULTURE BIOREACTOR

 #16 | 2023-03-09
US20230072523A1
Human necessities

PROCESS AND SYSTEM FOR ACELLULAR THERAPY

 #17 | 2022-09-08
US20220282195A1
Chemistry; metallurgy

MOBILE PROCESSING UNIT AND LABORATORIES

 #18 | 2022-09-01
US20220273774A1
Human necessities

PROPHYLACTIC PROTECTION AGAINST VIRAL INFECTIONS

 #19 | 2021-06-10
US20210171915A1
Chemistry; metallurgy

THREE DIMENSIONAL CLUSTERS OF TRANSDIFFERENTIATED CELLS, COMPOSITIONS AND METHODS THEREOF

 #20 | 2021-05-20
US20210145960A1
Human necessities

PROPHYLACTIC PROTECTION AGAINST VIRAL INFECTIONS, PARTICULARLY HIV

 #21 | 2021-02-25
US20210052506A1
Human necessities

BIOXOMES PARTICLES, REDOXOMES, METHOD AND COMPOSITION

 #22 | 2020-06-11 ✅ Patent 11,331,378 granted on 2022-05-17
US20200179493A1
Human necessities

Prophylactic protection against viral infections

 #23 | 2017-10-19 ✅ Patent 10,835,598 granted on 2020-11-17
US20170296647A1
Human necessities

Prophylactic protection against viral infections, particularly HIV

Also check out Orgenesis Inc.'s (Germantown, United States) applicant profile with 12 patent applications submitted.

AssigneeID:

307708 ⎘